» Articles » PMID: 32595418

LINC01094 Triggers Radio-resistance in Clear Cell Renal Cell Carcinoma Via MiR-577/CHEK2/FOXM1 Axis

Overview
Journal Cancer Cell Int
Publisher Biomed Central
Date 2020 Jun 30
PMID 32595418
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Radioresistance is an obstacle to limit efficacy of radiotherapy. Meanwhile, long non-coding RNAs (lncRNAs) have been reported to affect radioresistance. Here, we aimed to investigate lncRNAs involving radioresistance development of clear cell renal cell carcinoma (ccRCC), the most frequent type of renal cell carcinoma (RCC).

Methods: The mRNA and protein expressions of genes were measured via qRT-PCR and western blot. The relationships among genes were verified by RIP and luciferase reporter assay. The radioresistance of ccRCC cells was evaluated through clonogenic survival assay, MTT assay and TUNEL assay.

Results: LINC01094 was over-expressed in ccRCC cell lines. LINC01094 expression was increased along with the radiation exposure time and the final stable level was 8 times of the initial level. Knockdown of LINC01094 resulted in enhanced radiosensitivity of ccRCC cells. Mechanically, LINC01094 was a ceRNA of CHEK2 by sponging miR-577. Also, the enhancement of LINC01094 on ccRCC radioresistance was mediated by CHEK2-stabilized FOXM1 protein.

Conclusion: LINC01094 facilitates ccRCC radioresistance by targeting miR-577/CHEK2/FOXM1 axis, blazing a new trail for overcoming radioresistance in ccRCC.

Citing Articles

Identification of lncRNA dual targeting PD-L1 and PD-L2 as a novel prognostic predictor for gastric cancer.

Zhang L, Chen J, Liu Y, Zhang Y, Hong L, Li X Front Oncol. 2024; 14:1341056.

PMID: 39525623 PMC: 11544118. DOI: 10.3389/fonc.2024.1341056.


LINC01094: A key long non-coding RNA in the regulation of cancer progression and therapeutic targets.

Yi Q, Zhu G, Zhu W, Wang J, Ouyang X, Yang K Heliyon. 2024; 10(18):e37527.

PMID: 39309878 PMC: 11415682. DOI: 10.1016/j.heliyon.2024.e37527.


TGF-β1-Induced LINC01094 promotes epithelial-mesenchymal transition in hepatocellular carcinoma through the miR-122-5p/TGFBR2-SAMD2-SMAD3 Axis.

Yang X, Xu C, Liu C, Wu X, Chen X, Hou J Funct Integr Genomics. 2024; 24(4):123.

PMID: 38992207 DOI: 10.1007/s10142-024-01403-1.


A new ferroptosis-related signature model including messenger RNAs and long non-coding RNAs predicts the prognosis of gastric cancer patients.

Liu Y, Liu Y, Ye S, Feng H, Ma L J Transl Int Med. 2023; 11(2):145-155.

PMID: 38025952 PMC: 10680379. DOI: 10.2478/jtim-2023-0089.


Identification of a pyroptosis-related long non-coding RNA Signature for prognosis and its related ceRNA regulatory network of ovarian cancer.

Xu H, Lu M, Liu Y, Ren F, Zhu L J Cancer. 2023; 14(16):3151-3168.

PMID: 37859811 PMC: 10583579. DOI: 10.7150/jca.88485.


References
1.
Schaue D, McBride W . Opportunities and challenges of radiotherapy for treating cancer. Nat Rev Clin Oncol. 2015; 12(9):527-40. PMC: 8396062. DOI: 10.1038/nrclinonc.2015.120. View

2.
Santivasi W, Xia F . Ionizing radiation-induced DNA damage, response, and repair. Antioxid Redox Signal. 2013; 21(2):251-9. DOI: 10.1089/ars.2013.5668. View

3.
Wang Y, Lu Z, Wang N, Feng J, Zhang J, Luan L . Long noncoding RNA DANCR promotes colorectal cancer proliferation and metastasis via miR-577 sponging. Exp Mol Med. 2018; 50(5):1-17. PMC: 5938019. DOI: 10.1038/s12276-018-0082-5. View

4.
Mercer T, Dinger M, Mattick J . Long non-coding RNAs: insights into functions. Nat Rev Genet. 2009; 10(3):155-9. DOI: 10.1038/nrg2521. View

5.
Ficarra V, Guille F, Schips L, de la Taille A, Prayer Galetti T, Tostain J . Proposal for revision of the TNM classification system for renal cell carcinoma. Cancer. 2005; 104(10):2116-23. DOI: 10.1002/cncr.21465. View